Long-term Safety and Efficacy in Patients with DMD 4 Years Post-Treatment with Delandistrogene Moxeparvovec (SRP-9001) in a Phase 1/2a Study (P3-8.006)Jerry Mendell,Zarife Sahenk,Kelly Lehman,Linda Lowes,Natalie Reash,Megan Iammarino,Lindsay Alfano,Sarah Lewis,Kathleen Church,Richard Shell,Rachael Potter,Danielle Griffin,Mark Hogan,Shufang Wang,Stefanie Mason,Eddie Darton,Louise Rodino-KlapacNeurology（2023）引用 0|浏览3关键词DystrophinAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
